Once a treatment starts scaling up for clinical use, any gap in vector production could bring costly delays, both for developers expecting a return on their investment, and for patients waiting to ...

These plasmids are cotransfected into the producer cell line to ultimately generate viral particles (see schematic). Although lentiviral vector production techniques have matured in recent years ...

The Gene Vector Core was founded in 1997 as the Adenovirus Vector Production Core. Over the years, we have extended our expertise to other popular viral vector systems. Our core has been one of BCM ...